Matt Masinga

Is AI Starting Its Career by Replacing Gen Z Tech Workers?

AI has officially gone from writing bad poems and finishing your half-baked

Is This the Most Democratic Biotech Cap Table You’ve Ever Seen?

Only 9 Days Left to Invest at $3.00/Share, Raise Closes

Is YouTube Turning Into the Internet’s Babysitter?

YouTube is rolling out a new experiment in the U.S. where

Could AI Save You From the Superbug Apocalypse?

Let’s be honest, science headlines these days sound like rejected Marvel

If Meta’s AI Can Flirt With Kids, What Else Is It Allowed to Do?

Picture this: your kid is chatting with an AI bot on an

What’s Equity Crowdfunding And Why Does It Matter Now?

The window closes on August 27, and the price is $3.00/

Is “AGI” Just the AI World’s Favorite Fairy Tale?

OpenAI’s CEO, Sam Altman, just pulled a move you rarely see

Is This Biotech Really Funded by the People, Not Wall Street?

Final Countdown: Cytonics’ Reg A+ Raise Closes August 27th.  Most biotech cap

Is Google Handing Chrome to a Startup Nobody Can Spell?

Perplexity AI, a shiny new tech startup, just slapped a $34.5

What Makes Cytonics Different And Why Should You Trust Them?

Because in biotech, the “who” matters just as much as the “what”

Is Apple Picking Its Favorite AI Like It’s Choosing a Favorite Child?

Elon Musk says Apple is playing favorites in the App Store, and

Did OpenAI Just Learn That “Smarter” AI Isn’t Always Better?

OpenAI just pulled the tech version of taking your favorite menu item,